谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study

Melinda J. Gooderham,Stephan Weidinger,Eric L. Simpson,Mette Deleuran,Linda F. Stein Gold,Saleem A. Farooqui,Pinaki Biswas,Gary Chan,Erman Guler,Herwig Koppensteiner

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用 0|浏览21
关键词
abrocitinib,atopic dermatitis,dupilumab,Janus kinase inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要